JACOBS LEVY EQUITY MANAGEMENT, INC – Intercept Pharmaceuticals, Inc. Transaction History
JACOBS LEVY EQUITY MANAGEMENT, INC portfolio value:
$10.89M
portfolio value
JACOBS LEVY EQUITY MANAGEMENT, INC quarter portfolio value change:
+1.01%
quarter
Intercept Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +20.95% | 135.25K shares | 1.97M | $13.95 | 780.94K |
| Q2 2022 | share | Increase | +9.01% | 53.38K shares | -720K | $13.81 | 645.69K |
| Q1 2022 | share | Increase | +0.57% | 3.38K shares | 43K | $16.27 | 592.30K |
| Q4 2021 | share | Increase | +10.25% | 54.74K shares | 1.66M | $16.31 | 588.92K |
| Q3 2021 | share | Decrease | -12.98% | -79.71K shares | -4.32M | $14.85 | 534.17K |
| Q2 2021 | share | Increase | +15.37% | 81.78K shares | -22K | $19.97 | 613.88K |
| Q1 2021 | share | Increase | +10.92% | 52.37K shares | 432K | $23.08 | 532.10K |
| Q4 2020 | share | Increase | +38.15% | 132.47K shares | -2.54M | $24.7 | 479.72K |
| Q3 2020 | share | Increase | +602.12% | 297.78K shares | 12.02M | $41.46 | 347.24K |
| Q2 2020 | share | Increase | +12.40% | 5.45K shares | -401K | $47.91 | 49.45K |
| Q1 2020 | share | Decrease | -0.77% | -340 shares | -2.72M | $62.96 | 44.00K |
| Q4 2019 | share | Increase | +10.05% | 4.05K shares | 2.82M | $123.92 | 44.34K |
| Q3 2019 | share | Increase | 0.00% | 40.29K shares | 2.67M | $66.36 | 40.29K |
| Q3 2016 | share | Decrease | -100.00% | -8.12K shares | -1.15M | $164.59 | 0 |
| Q2 2016 | share | Decrease | -37.73% | -4.92K shares | -516K | $142.68 | 8.12K |
| Q1 2016 | share | Increase | 0.00% | 13.04K shares | 1.67M | $128.47 | 13.04K |